Global abnormalities in lymphatic function following systemic therapy in patients with breast cancer

E-ISSN： 1365-2168|102|5|534-540

ISSN： 0007-1323

Source： BRITISH JOURNAL OF SURGERY, Vol.102, Iss.5, 2015-04, pp. : 534-540

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Primary systemic therapy in patients with breast cancer: rationale of use and magnitude of evidence

By Puglisi Fabio Minisini Alessandro Piga Andrea

Therapy, Vol. 1, Iss. 1, 2004-09 ,pp. : 91-100

Future Medicine

Access to resources Recommend Favorite

Adjuvant systemic therapy for elderly women with breast cancer

By Henry N Lynn Diehl Kathleen M Hayes Daniel F

Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. : 75-87

Future Medicine

Access to resources Recommend Favorite

Editorial: Primary Systemic Therapy for Breast Cancer

Reviews on Recent Clinical Trials, Vol. 12, Iss. 2, 2017-05 ,pp. : 66-66

Bentham Science Publishers

Access to resources Recommend Favorite

Will trastuzumab change the optimal adjuvant systemic therapy of patients with HER2-positive breast cancer?

By Santini Daniele Vincenzi Bruno Tonini Giuseppe

Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. : 1-3

Future Medicine

Access to resources Recommend Favorite

Prognosis for patients with metastatic breast cancer who achieve a no‐evidence‐of‐disease status after systemic or local therapy

CANCER, Vol. 121, Iss. 24, 2015-12 ,pp. : 4324-4332

John Wiley & Sons Inc

Access to resources Recommend Favorite